TheStreet Quant Ratings rates UnitedHealth Group Inc. (NYSE:UNH) as a buy. The company’s strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and attractive valuation levels. UnitedHealth Group Inc. (NYSE:UNH) shares after opening at $1.96 on last trade day and at the end of the day closed at $81.53. Company price to sales ratio in past twelve months was calculated as 0.66 and price to cash ratio as 11.17. UnitedHealth Group Inc. (NYSE:UNH)showed a positive weekly performance of 5.87%.
Mizuho started coverage on shares of ZIOPHARM Oncology (NASDAQ:ZIOP) in a research note released on Wednesday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $11.00 target price on the stock. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) shares advanced 11.75% in last trading session and ended the day on $5.42. ZIOP return on equity ratio is recorded as -207.30% and its return on assets is -108.70%. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) yearly performance is 1.69%.
Aetna Inc (NYSE:AET) has led a best-in-class team to expand the capabilities of one of the nation’s first private health exchanges for large employers, giving retirees greater purchasing power, more choices, and help choosing a plan to meet their needs. HR Policy Association, representing the chief human resource officers of more than 350 of the largest private sector employers in the United States, chose Aetna to create the next generation of its highly successful Retiree Health Access (RHA) program. Aetna Inc (NYSE:AET) shares moved up 0.83% in last trading session and was closed at $75.39, while trading in range of $74.65 – $76.38. Aetna Inc (NYSE:AET) year to date (YTD) performance is 9.91%.
Investment analysts at JPMorgan Chase & Co. set a $150.00 target price on shares of Humana (NYSE:HUM) stock in a note issued to investors on Thursday, Stock Ratings Network reports. JPMorgan Chase & Co.’s price objective suggests a potential upside of 28.25% from the company’s current price. Humana Inc (NYSE:HUM) weekly performance is 8.36%. On last trading day company shares ended up $118.78. Humana Inc (NYSE:HUM) distance from 50-day simple moving average (SMA50) is 15.67%. Analysts mean target price for the company is $105.67.